Christine Borowski

Christine Borowski joined Access Biotechnology as a Senior Associate in July 2019.
Prior to that she worked on therapeutics company creation at Apple Tree Partners.
Before becoming an investor, Christine worked as an editor at several high-impact scientific journals, most recently as Chief Editor of Nature Medicine.
She earned a Ph.D.
in Immunology at Harvard University, studying thymocyte development in the laboratory of Harald von Boehmer.
Her postdoctoral work in the lab of Albert Bendelac at the University of Chicago focused on natural killer T cell development.